Effects of immunization against PCSK9 in an experimental model of breast cancer.

Arch Med Sci · 2019 · PMC6524183 · PMID 31110521

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Further, long-term analysis revealed that anti-PCSK9 antibody titer reached peak levels at week 8 and remained constant up to week 10, and then showed a decreasing trend ( Figure 2 A ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.